期刊文献+

肝癌患者血清中CD44v6、HMGB1以及GP73含量检测及其与肿瘤组织中JAK-STAT通路的关系 被引量:8

Detection of serum CD44v6,HMGB1,GP73 contents of liver cancer patients and its correlation with JAK-STAT pathway in tumor tissue
下载PDF
导出
摘要 目的:研究肝癌患者血清中CD44v6、HMGB1以及GP73含量及其与肿瘤组织中JAK-STAT通路的相关性。方法:选择在本院确诊为原发性肝癌的60例患者作为观察组,将同期在本院体检明确身体健康的60例健康者作为对照组,采集血清后检测CD44v6、HMGB1、GP73含量,收集肝癌和癌旁组织并检测JAK-STAT信号分子及下游调节基因的mRNA含量。结果:与对照组比较,观察组血清中CD44v6、HMGB1以及GP73的含量较高,差异有统计学意义(P<0.05);肝癌组织中JAK1、JAK2、STAT1、STAT3、STAT5的表达量高于癌旁组织,差异有统计学意义(P<0.05);肝癌组织中TCF21、Pim1、VEGF、HIF-1α、ICAM-1、VCAM-1的表达量高于癌旁组织,差异有统计学意义(P<0.05);血清CD44v6、HMGB1以及GP73含量与JAK1、JAK2、STAT1、STAT3、STAT5的表达量呈正相关。结论:肝癌患者血清中肿瘤标志分子血清中CD44v6、HMGB1以及GP73含量异常升高且与肝癌组织中JAK-STAT通路的激活密切相关。 Objective:To study the serum CD44v6,HMGB1,GP73 contents of liver cancer patients and its correlation with JAK-STAT pathway in tumor tissue.Methods:60cases of patients diagnosed as primary liver cancer in our hospital from2013/6-2014/8were enrolled as observation group,60 cases of healthy people judged by health examination in our hospital during the same period were enrolled as control group.Then serum was collected and CD44v6,HMGB1,GP73 contents were assayed,hepatocellular carcinoma tissue and paracancerous tissues were collected and JAK-STAT signal molecules and downstream regulatory gene were assayed.Results:(1)Serum indexes:compared with serum hepatocellular carcinoma marker molecules,CD44v6,HMGB1,GP73 contents in serum of observation group were lower;(2)JAK-STAT pathway:JAK1,JAK2,STAT1,STAT3,STAT5 expression in hepatocellular carcinoma tissue were higher than those in paracancerous tissues;(3)Signaling pathway regulates gene:TCF21,Pim1,VEGF,HIF-1α,ICAM-1,VCAM-1expression in hepatocellular carcinoma tissue were higher than those in paracancerous tissues;(4)Serum CD44v6,HMGB1 and GP73contents were positively correlated with JAK1,JAK2,STAT1,STAT3,STAT5 expression.Conclusion:Serum tumor marker molecules CD44v6,HMGB1 and GP73contents of liver cancer patients abnormally increase and have correlation with the activation of JAK-STAT pathway in hepatocellular carcinoma tissue.
作者 殷盈祥
出处 《海南医学院学报》 CAS 2015年第9期1275-1277,1280,共4页 Journal of Hainan Medical University
基金 山东省医学科学院国家自然基金(30571502)~~
关键词 原发性肝癌 肿瘤标志物 信号通路 Janus蛋白酪氨酸激酶 信号转导和转录激活子 Primary liver cancer Tumor marker Signal pathway Janus kinase Signal transducers and activator of transcription
  • 相关文献

参考文献15

  • 1Zhou ZJ, Dai Z, Zhou SL, et al. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indi- cates poor prognosis for hepatocellular carcinoma [-J;. Int J Cancer, 2013, 132(5) :1080-1099.
  • 2陈科济,范飞,朱斌,马优钢,张永杰.肝癌患者血清高迁移率族蛋白B1的表达及与p53和临床病理的相关性[J].第二军医大学学报,2012,33(1):103-105. 被引量:4
  • 3Zhang L, Han J,Wu H, et al. The association of HMGB1 ex- pression with elinieopathologieal significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review [J]. PLoS One, 2014, 9(10) :e110626.
  • 4Cao FF,Yu S,Jiang ZY,et al. Diagnostic accuracy of Golgi pro- tein 73 in primary hepatic carcinoma using ELISA: a systematic review and rneta-analysis[J]. Clin Lab, 2014, 60(4) :587-597.
  • 5Wang NY,Wang C, Li W, He H, et al. Prognostic value of ser- um AFP, AFP-L3, and GP73 in monitoring short-term treat- ment response and recurrence of hepatocellular carcinoma after radiofrequeney ablation[J]. Asian Pac J Cancer Prey, 2014, 15 (4) : 1539-1544.
  • 6王建强,黄缘.JAK-STAT信号通路在肝癌发生发展中作用的研究进展[J].世界华人消化杂志,2013,21(21):2051-2056. 被引量:22
  • 7Senggunprai L, Kukongviriyapan V, Prawan A, et al. Quercetin and EGCG exhibit chemopreventive effects in cholangioearcino- ma cells via suppression of JAK/STAT signaling pathway[J]. Phytother Res, 2014, 28(6):841-848.
  • 8Gao B,Wang H,Lafdil F,et al. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver[J]. J Hepatol, 2012, 57(2) :430-441.
  • 9Ye YW,Jiang ZM, Li WH, et al. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma ]-J;. Neoplasma, 2012, 59(6): 599 605.
  • 10Weirauch U, Beckmann N, Thomas M, et al. Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma[J]. Neoplasia, 2013, 15(7) :783-794.

二级参考文献20

  • 1邱伟华,Bingsen Zhou,Dana Darwish,Peiguo G.Chu,Frank Luh,陈皓,杨卫平,李宏为,Yun Yen.STAT3在SAMe抑制HepG2细胞VEGF表达中的作用[J].上海交通大学学报(医学版),2006,26(6):576-580. 被引量:6
  • 2Kostova N,Zlateva S,Ugrinova I,Pasheva E,Pasheva E.Theexpression of HMGB1protein and its receptor RAGE in humanmalignant tumors[J].Mol Cell Biochem,2010,337:251-258.
  • 3Akaike H,Kono K,Sugai H,Takahashi A,Mimura K,Kawagu-chi Y,et al.Expression of high mobility group box chromosomalprotein-1(HMGB-1)in gastric cancer[J].Anticancer Res,2007,27(1A):449-457.
  • 4Liu P L,Tsai J R,Hwang J J,Chou S H,Cheng Y J,Lin F Y,et al.High-mobility group box 1-mediated matrix metalloproteinase-9expression in non-small cell lung cancer contributes to tumor cellinvasiveness[J].Am J Respir Cell Mol Biol,2010,43:530-538.
  • 5Ohmori H,Luo Y,Kuniyasu H.Non-histone nuclear factorHMGB1as a therapeutic target in colorectal cancer[J].ExpertOpin Ther Targets,2011,15:183-193.
  • 6Mantell L L,Parrish W R,Ulloa L.Hmgb-1as a therapeutictarget for infectious and inflammatory disorders[J].Shock,2006,25:4-11.
  • 7Banerjee S,Kundu T K.The acidic C-terminal domain and A-box of HMGB-1regulates p53-mediated transcription[J].Nucleic Acids Res,2003,31:3236-3247.
  • 8Goh A M,Coffill C R,Lane D P.The role of mutant p53in hu-man cancer[J].J Pathol,2011,223:116-126.
  • 9Tommasi S,Pinto R,Pilato B,Paradiso A.Molecular pathwaysand related target therapies in liver carcinoma[J].Curr PharmDes,2007,13:3279-3287.
  • 10Parkin D M,Bray F,Ferlay J,Pisani P.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55:74-108.

共引文献24

同被引文献58

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部